| Clinical Science: Special Reports - I |  Jay H. Traverse, MD, FAHA Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minn. | LateTIME Results From LateTIME: A Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two to Three Weeks Following Acute Myocardial Infarction Discussant: Thomas Eschenhagen, MD, Hamburg, Germany | |
 Emerson C. Perin, MD, PhD Texas Heart Institute, Houston, Texas | A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic and Nonischemic Heart Failure Discussant: Milica Radisic, PhD, Cambridge, Mass. | |
 Andreas M. Zeiher, MD J. W. Goethe University, Frankfurt, Germany | CELLWAVE Trial Cardiac Extracorporal Shock Wave Application to Enhance the Efficiency of Intracoronary Cell Therapy in Chronic Heart Failure - Results of the Randomized, Double-Blind, Placebo-Controlled CELLWAVE Trial Discussant: Hina Chaudhry, MD, New York, N.Y. | |
 Eduardo Marban, MD, PhD, FAHA Cedars Sinai Heart Institute, Los Angeles, Calif. | CADUCEUS Trial The CADUCEUS (CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction) Trial Discussant: Charles E. Murry, MD, PhD, Seattle, Wash. | | | |
| Clinical Science: Special Reports - II |  Todd McAllister, PhD Cytograft/St. Joseph's Translational Res Institute, Novato, Calif. | First Human Use of an Allogeneic Tissue Engineered Vascular Graft Discussant of First Human Use of an Allogeneic Tissue Engineered Vascular Graft Discussant: Frank W. Sellke, MD, FAHA, Providence, R.I. | |
 Robert-Jan van Geuns, MD, PhD Thoraxcenter, Rotterdam, Netherlands | ABSORB Cohort B Trial ABSORB Cohort B Trial: Two Year OCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold Discussant: Marco Costa, MD, Cleveland, Ohio | |
 David Leistner, MD Birgit Assmus, University Hospital of Frankfurt, Frankfurt am Main, Germany | REPAIR-AMI Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Acute Myocardial Infarction: 5 Year Clinical Outcome and MRI Data of the Randomized, Double-Blind, Placebo-Controlled REPAIR-AMI Trial Discussant: Robert O. Bonow, MD, FAHA, Chicago, Ill. | |
 Robert D. Dowling, MD DCI, Inc, Louisville, Ky. | Development of a Long-Term Synchronous Device for Partial Circulatory Support Discussant: Timothy J. Gardner, MD, FAHA, Newark, DE | |